हिंदी में पढ़ें

Home
/Dr Reddy's Laboratories

Dr Reddy's Laboratories

Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today

Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today

Wed, January 25, 2023

Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug

Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug

Mon, December 19, 2022

Dr Reddy’s out of Sensex pack; Tata Motors is new entrant - Check full list of 30 companies | Sensex Reshuffle December 2022

Dr Reddy’s out of Sensex pack; Tata Motors is new entrant - Check full list of 30 companies | Sensex Reshuffle December 2022

Mon, December 19, 2022

Sensex Companies List 2022: Tata Motors to replace Dr Reddy's in S&P BSE Sensex from tomorrow

Sensex Companies List 2022: Tata Motors to replace Dr Reddy's in S&P BSE Sensex from tomorrow

Fri, December 16, 2022

Dr Reddy's, Sun Pharma recall products in US for manufacturing issues

Dr Reddy's, Sun Pharma recall products in US for manufacturing issues

Mon, December 5, 2022

Sensex reshuffle: Tata Motors to replace Dr Reddy’s, effective from December 19

Sensex reshuffle: Tata Motors to replace Dr Reddy’s, effective from December 19

Mon, November 21, 2022

RECOMMENDED

Dr Reddy's Laboratories share trade in green in early trade with over 1% surge after Q2 result: Check target given by brokerages

Dr Reddy's Laboratories share trade in green in early trade with over 1% surge after Q2 result: Check target given by brokerages

Mon, October 31, 2022

Dr Reddy's Lab inks licensing pact with US-based Slayback Pharma

Dr Reddy's Lab inks licensing pact with US-based Slayback Pharma

Sat, July 30, 2022

Dr Reddy’s Lab share price cracks nearly 5% amid lower-than-expected Q1 earnings – know what brokerages say

Dr Reddy’s Lab share price cracks nearly 5% amid lower-than-expected Q1 earnings – know what brokerages say

Fri, July 29, 2022

Dr Reddy's shares surge 8% post q4 earnings; What should investors do?

Dr Reddy's shares surge 8% post q4 earnings; What should investors do?

Fri, May 20, 2022

Dr Reddy's Q4 Results: PAT down 76% YoY on impacted by impairment charges; company announces dividend of Rs 30

Dr Reddy's Q4 Results: PAT down 76% YoY on impacted by impairment charges; company announces dividend of Rs 30

Thu, May 19, 2022

Technical Check: After forming a double bottom pattern Divi’s Laboratories eyes 20% upside in next 6-9 months

Technical Check: After forming a double bottom pattern Divi’s Laboratories eyes 20% upside in next 6-9 months

Fri, March 25, 2022

Buy, Sell or Hold: What should investors do with Dr Reddy’s Laboratories, Hero MotoCorp and TCS?

Buy, Sell or Hold: What should investors do with Dr Reddy’s Laboratories, Hero MotoCorp and TCS?

Wed, March 23, 2022

8 Nifty50 stocks including HDFC twins, Dr Reddy’s, UltraTech, HUL hit 52-week lows; here is what brokerage opines

8 Nifty50 stocks including HDFC twins, Dr Reddy’s, UltraTech, HUL hit 52-week lows; here is what brokerage opines

Fri, March 4, 2022

Buy, Sell or Hold: What should investors do with Maruti Suzuki, HDFC and Dr Reddy’s Laboratories?

Buy, Sell or Hold: What should investors do with Maruti Suzuki, HDFC and Dr Reddy’s Laboratories?

Thu, March 3, 2022

Dr Reddy’s Q3FY22: Pharma major reports Rs 707 cr PAT, sales surge 8% YoY; margins dip

Dr Reddy’s Q3FY22: Pharma major reports Rs 707 cr PAT, sales surge 8% YoY; margins dip

Fri, January 28, 2022

Dr Reddy’s Q3FY22 Preview: Net profit, sales could see double-digit YoY growth for this pharma major

Dr Reddy’s Q3FY22 Preview: Net profit, sales could see double-digit YoY growth for this pharma major

Wed, January 26, 2022

Outlook 2022: Pharma, healthcare sector looks to sustain momentum, say industry leaders

Outlook 2022: Pharma, healthcare sector looks to sustain momentum, say industry leaders

Thu, December 23, 2021

Dr Reddy's launches drug to treat high blood pressure, heart failure in US market

Dr Reddy's launches drug to treat high blood pressure, heart failure in US market

Thu, December 9, 2021

Sanjiv Bhasin picks these two stocks for gains- check target price, stop loss, other details

Sanjiv Bhasin picks these two stocks for gains- check target price, stop loss, other details

Wed, October 27, 2021

1
2
3
4

Top News